This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fiskus, W. Articles by Bhalla, K. Search for Related Content PubMed PubMed Citation Articles by Fiskus, W. Articles by Bhalla, K.

Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor- Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90

Authors' Affiliations: ¹ Medical College of Georgia Cancer Center, Augusta, Georgia; ² H. Lee Moffitt Cancer Center, Tampa, Florida; ³ Yale University, New Haven, Connecticut; and ⁴ Novartis Pharmaceuticals, Inc., Cambridge, Massachusetts

Requests for reprints: Kapil Bhalla, MCG Cancer Center, Medical College of Georgia, 1120 15th Street, CN-2101 Augusta, GA 30912. Phone: 706-721-0566; Fax: 706-721-0469; E-mail: kbhalla{at}mcg.edu.

Purpose: The molecular chaperone heat shock protein (hsp)-90 maintains estrogen receptor (ER)- in an active conformation, allowing it to bind 17ß-estradiol (E₂) and transactivate genes, including progesterone receptor (PR)-ß and the class IIB histone deacetylase HDAC6. By inhibiting HDAC6, the hydroxamic acid analogue pan-HDAC inhibitors (HA-HDI; e.g., LAQ824, LBH589, and vorinostat) induce hyperacetylation of the HDAC6 substrates -tubulin and hsp90. Hyperacetylation of hsp90 inhibits its chaperone function, thereby depleting hsp90 client proteins. Here, we determined the effect of HA-HDIs on the levels and activity of ER, as well as on the survival of ER-expressing, estrogen-responsive human breast cancer MCF-7 and BT-474 cells.

Experimental Design: Following exposure to HA-HDIs, hsp90 binding, polyubiquitylation levels, and transcriptional activity of ER, as well as apoptosis and loss of survival, were determined in MCF-7 and BT-474 cells.

Results: Treatment with HA-HDI induced hsp90 hyperacetylation, decreased its binding to ER, and increased polyubiquitylation and depletion of ER levels. HA-HDI treatment abrogated E₂-induced estrogen response element-luciferase expression and attenuated PRß and HDAC6 levels. Exposure to HA-HDI also depleted p-Akt, Akt, c-Raf, and phospho-extracellular signal–regulated kinase-1/2 levels, inhibited growth, and sensitized ER-positive breast cancer cells to tamoxifen.

Conclusions: These findings show that treatment with HA-HDI abrogates ER levels and activity and could sensitize ER-positive breast cancers to E₂ depletion or ER antagonists.

This article has been cited by other articles:

				Y. Yang, R. Rao, J. Shen, Y. Tang, W. Fiskus, J. Nechtman, P. Atadja, and K. Bhalla Role of Acetylation and Extracellular Location of Heat Shock Protein 90{alpha} in Tumor Cell Invasion Cancer Res., June 15, 2008; 68(12): 4833 - 4842. [Abstract] [Full Text] [PDF]